[HTML][HTML] Boron neutron capture therapy: Current status and challenges
S Wang, Z Zhang, L Miao, Y Li - Frontiers in Oncology, 2022 - frontiersin.org
Boron neutron capture therapy (BNCT) is a re-emerging therapy with the ability to selectively
kill tumor cells. After the boron delivery agents enter the tumor tissue and enrich the tumor …
kill tumor cells. After the boron delivery agents enter the tumor tissue and enrich the tumor …
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting …
Re-irradiation can be considered for local recurrence or new tumours adjacent to a
previously irradiated site to achieve durable local control for patients with cancer who have …
previously irradiated site to achieve durable local control for patients with cancer who have …
One step synthesis of 10B-enriched 10BPO4 nanoparticles for effective boron neutron capture therapeutic treatment of recurrent head-and-neck tumor
N Kuthala, M Shanmugam, CL Yao, CS Chiang… - Biomaterials, 2022 - Elsevier
Recurrent head-and-neck (H&N) cancer is one of the most malignant cancers in the world.
Various treatment modalities, such as radiation therapy, chemotherapy, and surgery were …
Various treatment modalities, such as radiation therapy, chemotherapy, and surgery were …
Reirradiation using 198Au grain brachytherapy for recurrent oral cancer cases previously treated by definitive radiotherapy
M Konishi, Y Takeuchi, K Kubo, N Imano… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: We investigated treatment outcomes and complications during
reirradiation of patients with oral cancers. Patients and Methods: Six patients who received …
reirradiation of patients with oral cancers. Patients and Methods: Six patients who received …
Head and Neck Cancer in Older Adults with Frailty
Abstract Head and Neck Cancer (HNC) is predominantly a disease of older adults despite a
rise in its incidence in younger patients related to human papillomavirus (HPV) infection …
rise in its incidence in younger patients related to human papillomavirus (HPV) infection …
[HTML][HTML] Treatment for Locoregionally Recurrent Head and Neck Cancers
M Kwon - Korean Journal of Otorhinolaryngology-Head and …, 2022 - synapse.koreamed.org
The locoregional recurrence rate after treatment of head and neck cancer (HNC) is known to
be about 40%, and recurrence of cancer is the major factor directly related to the survival of …
be about 40%, and recurrence of cancer is the major factor directly related to the survival of …
국소재발한두경부암의치료
권민수 - 대한이비인후-두경부외과학회지, 2022 - oldkmbase.medric.or.kr
The locoregional recurrence rate after treatment of head and neck cancer (HNC) is known
tobe about 40%, and recurrence of cancer is the major factor directly related to the survival …
tobe about 40%, and recurrence of cancer is the major factor directly related to the survival …